Roxadustat: Not just for anemia

• 主要な著者: Xiaoyu Zhu (著者), Lili Jiang (著者), Xuejiao Wei (著者), Mengtuan Long (著者), Yujun Du (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Roxadustat is a recently approved hypoxia-inducible factor prolyl hydroxylase inhibitor that has demonstrated favorable safety and efficacy in the treatment of renal anemia. Recent studies found it also has potential for the treatment of other hypoxia-related diseases. Although clinical studies have...